Sai Life Sciences Q4 Results
- BSE: 544306
- NSE: SAILIFE
- ISIN: INE570L01029
- Sector: Biotechnology & Drugs
BSE
1,262.55
-4.90 (-0.39%)
-4.90 (-0.39%)Volume11.52 K
Updated: Wed 15 Jul, 2026 | 15:28:46
NSE
1,263.20-5.60 (-0.44%)
-5.60 (-0.44%)Volume1.62 L
Updated: Wed 15 Jul, 2026 | 15:47:11
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹602.14 Cr.(3.91%)
- Operating Profit₹131.53 Cr.(9.53%)
- Profit After Tax₹104.24 Cr.(18.09%)
- Operating Margin21.84%(5.42%)
Note: Comparison is on YoY basis
Quarterly - Sai Life Sciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 470.61 | 420.98 | 11.79% | 1,299.13 | 2.43% |
| Depreciation/ Amortization | 45.31 | 44.08 | 2.80% | 119.44 | 20.86% |
| Operating Income | 131.53 | 135.48 | -2.92% | 166.05 | 9.53% |
| Net Income | 104.24 | 100.38 | 3.85% | 82.81 | 18.09% |
| Other Operating Expenses Total | 77.23 | 67.67 | 14.12% | 0.30 | -25.11% |
| Net Income Before Taxes | 139.23 | 134.17 | 3.77% | 109.23 | 17.20% |
| Total Revenue | 602.14 | 556.46 | 8.21% | 1,465.18 | 3.91% |
| Selling/ General/ Admin Expenses Total | 186.65 | 172.99 | 7.90% | 640.14 | 23.54% |
| Diluted Normalized EPS | 4.86 | 5.00 | -2.83% | 3.98 | 21.45% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.